Aquaporin-5 Expression Is Reduced in Lymphocytic Colitis

Area of Science:

• Gastroenterology
• Cell Biology
• Molecular Biology

Background:

• Aquaporin-5 (AQP5) facilitates water transport across cell membranes.
• Lymphocytic colitis (LC) and collagenous colitis (CC) cause chronic watery diarrhea with often normal-appearing colonic mucosa.
• Understanding AQP5's role in these conditions is crucial for diagnosis and treatment.

Purpose of the Study:

• To investigate alterations in AQP5 expression in the colonic epithelium of patients with LC and CC.
• To correlate AQP5 expression levels with clinical presentation and treatment response.

Main Methods:

• Immunohistochemistry was used to assess AQP5 expression in colorectal biopsies.
• Biopsies from control patients, patients with chronic diarrhea, LC patients, and CC patients were analyzed.
• AQP5 staining intensity was quantitatively scored.

Main Results:

• Strong AQP5 expression was observed in control and chronic diarrhea groups.
• Collagenous colitis (CC) showed preserved or moderately reduced AQP5 expression.
• Lymphocytic colitis (LC) exhibited significantly reduced AQP5 expression in a majority of cases (p=0.0031).

Conclusions:

• Colorectal AQP5 expression is significantly decreased in most LC patients.
• Markedly reduced AQP5 may identify LC patients with a poor response to enteric steroid therapy.
• Further large-scale studies are warranted to validate these findings and their clinical implications.